Загрузка...
High Dose Infliximab in the Treatment of Refractory Uveitis: Does Dose Matter?
Background. Infliximab (INF) has been shown to be beneficial in treating refractory uveitis, however, no data exist on optimal dosing and the efficacy of higher dosing. Objectives. To compare the efficacy of low-dose (LD) (<10 mg/kg), moderate-dose (MD) (≥10–15 mg/kg), and high-dose (HD) INF (≥15...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
International Scholarly Research Network
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3263752/ https://ncbi.nlm.nih.gov/pubmed/22389806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2012/765380 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|